Patent · US Active

Inhibitors of transglutaminases

US11072634B2 · kind B2 · utility

3Cited by

0References

13Claims

0Family size

Assignee

Zedira GmbH · DE

Inventors

Martin Hils · Darmstadt, DE
Ralf Pasternack · Griesheim, DE
Christian Büchold · Karben, DE

Key dates

Filing date	Jan 2, 2018
Grant date	Jul 27, 2021
Priority date	—
Expiry date	Jan 2, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the compound of general formula (I) as novel inhibitors of transglutaminases, to methods for producing the inventive compounds, to pharmaceutical compositions containing said inventive compounds and to their use for the prophylaxis and treatment of diseases associated with transglutaminases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.